- Full Year 2023 Santhera Pharmaceuticals Holding AG Earnings Call TranscriptApr 25, 2024CHF9.5 (+0.42%)Earnings
- Santhera Pharmaceuticals Holding AG at HC Wainwright Investment Conference - New York TranscriptSep 12, 2023
- Santhera Pharmaceuticals Holding AG To Discuss The Agreement on Vamorolone TranscriptJun 20, 2023
- Full Year 2022 Santhera Pharmaceuticals Holding AG Earnings Call TranscriptApr 27, 2023CHF6.3 (-8.70%)Earnings
- Half Year 2022 Santhera Pharmaceuticals Holding AG Earnings Call TranscriptNov 07, 2022CHF5.84 (-1.02%)Earnings
- Full Year 2021 Santhera Pharmaceuticals Holding AG Earnings Call TranscriptJun 10, 2022CHF10.6 (+0.76%)Earnings
- Santhera Pharmaceuticals Holding AG Investor Conference Call - Looking Ahead to 2022 TranscriptDec 08, 2021
- Q2 2021 Santhera Pharmaceuticals Holding AG Earnings Call TranscriptSep 22, 2021CHF14.8 (-1.86%)Earnings
- Q4 2020 Santhera Pharmaceuticals Holding AG Earnings Call TranscriptApr 29, 2021CHF26.3 (-7.88%)Earnings
Santhera Pharmaceuticals Holding AG at HC Wainwright Investment Conference - New York Transcript
Good morning. Thank you for joining the H.C. Wainwright 25th Annual Global Investment Conference. My name is Oren Livnat, specialty pharmaceuticals analyst here at H.C. Wainwright. It's my pleasure to welcome our next presenter, Dario Eklund, CEO of Santhera Pharmaceuticals, Swiss specialty pharmaceutical company focused on rare neuromuscular and pulmonary diseases with its lead asset having a very near-term October PDUFA date. Sounds quite exciting, so I look to hearing more.
Please take it away, Dario.
Thank you, Oren, and thank you to H.C. Wainwright for inviting us to speak today. I'm excited to be here because we're getting very close to an inflection point with the mentioned FDA PDUFA date. First, I'd like to start with a greeting from our legal department. I will be making forward-looking statements during this presentation.
So as already mentioned, we're a Swiss-based company. I'll cover a little bit of background on the company
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)